← Back to catalogue
ENQUIRE ABOUT THIS RESEARCH COMPOUND →
Performance & Recovery
CJC 1295 NO DAC + Ipamorelin
10mg
This blend pairs a GHRH analogue with a growth-hormone secretagogue for research involving coordinated GH-pathway signalling.
Research focusCombined GHRH and secretagogue research
PresentationLyophilised peptide blend · 10mg · 3 mL vial
Research overview
This research blend combines a GHRH-pathway peptide with ipamorelin, a ghrelin-receptor agonist/growth-hormone secretagogue. The pairing is used experimentally to examine two distinct inputs into pulsatile GH signalling.
Evidence status
Component evidence varies
The components have separate pharmacology literature, but evidence for the exact combined formulation is more limited. Findings about one component should not automatically be attributed to the blend.
Research use only. Not for human consumption. This page is educational and does not provide medical advice or dosing guidance.
Areas under investigation
- GHRH and ghrelin-receptor pathways
- Pulsatile growth-hormone signalling
- Combined secretagogue research
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.